- CA$2.50m
- CA$6.33m
- $7.73m
- 66
- 99
- 30
- 71
2018 December 31st | C2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | fx Final | fx Final | fx Final | fx Final | Final |
Revenue | |||||
Total Revenue | 5.78 | 5.6 | 5.93 | 7.74 | 7.73 |
Cost of Revenue | |||||
Gross Profit | 5.47 | — | — | — | — |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 5.46 | 5.62 | 5.21 | 7.61 | 8.17 |
Operating Profit | 0.321 | -0.015 | 0.716 | 0.122 | -0.43 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 0.401 | -0.111 | 0.679 | -0.041 | 1.58 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.396 | -0.114 | 0.679 | -0.047 | 1.57 |
Net Income Before Extraordinary Items | |||||
Net Income | 0.396 | -0.114 | 0.679 | -0.047 | 1.57 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.396 | -0.114 | 0.679 | -0.047 | 1.57 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.006 | -0.002 | 0.018 | 0.002 | 0.027 |